Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
1. In a meta-analysis of studies on provider-based interventions aimed at promoting human papillomavirus (HPV) vaccination, the rate of HPV vaccine ...
1. The human papillomavirus (HPV) vaccine has been shown to be effective in protecting against quadrivalent HPV vaccine (4vHPV)-type infections ...
Click to read this study in JAMA Oncology.
1. Online training for pediatricians on human papillomavirus (HPV) communication strategies is associated with an increase in rates of HPV ...
1. No significant increase in spontaneous abortion, preterm birth, major structural defects, or small for gestational age rates were found ...
1. Vaccination against the ten selected pathogens is projected to avert 69 million deaths between 2000 and 2030. 2. Increases ...
1. Quadrivalent human papillomavirus (HPV) vaccination was associated with a substantial lower risk of invasive cervical cancer in Swedish girls ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.